| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.52B | +4.8% |
| Cost of Revenue | $723.2M | +2.5% |
| Gross Profit | $1.79B | +5.7% |
| R&D Expense | $317.0M | -3.7% |
| SG&A Expense | $258.4M | -3.0% |
| Operating Income | $120.6M | +4415.0% |
| Interest Expense | $57.5M | -9.3% |
| Pre-tax Income | $56.2M | +219.1% |
| Income Tax | $12.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $132.6M | -45.4% |
| Accounts Receivable | $384.1M | -0.6% |
| Inventory | $929K | -25.3% |
| Current Assets | $765.2M | -12.2% |
| Total Assets | $1.48B | -16.8% |
| Current Liabilities | $1.22B | +62.7% |
| Long-term Debt | $629.6M | -53.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $617.4M | +27.8% |
| Capital Expenditures | $30.1M | +20.4% |
| Investing Cash Flow | -$108.0M | +1.3% |
| Financing Cash Flow | -$623.4M | -77.6% |
| Free Cash Flow | $587.3M | +28.2% |
| +16.1% |
| Net Income | $43.4M | +174.4% |
| EPS (Basic) | $0.48 | +176.2% |
| EPS (Diluted) | $0.48 | +176.2% |
| Total Liabilities |
| $1.87B |
| -12.3% |
| Stockholders' Equity | -$588.1M | -6.8% |